XML 28 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
plan
Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of share-based compensation plans     3  
Outstanding assumed options (in shares) 375,000   375,000  
Additional shares authorized by Board of Directors (in shares)     4,000,000  
Shares authorized (in shares) 26,500,000   26,500,000  
Total unrecognized compensation expense $ 16,675,914   $ 16,675,914  
Number of shares [Roll forward]        
Outstanding, beginning of period (in shares)     15,375,960  
Granted (in shares)     2,948,969  
Exercised (in shares)     (1,146,987)  
Unvested options forfeited (in shares)     (249,670)  
Vested options expired (in shares)     (84,332)  
Outstanding, end of period (in shares) 16,843,940   16,843,940  
Vested at end of period (in shares) 8,987,368   8,987,368  
Exercisable options, vested and expected to vest (in shares) 16,515,621 [1]   16,515,621 [1]  
Weighted-Average Exercise Price [Roll forward]        
Outstanding, weighted average exercise price, beginning of period (in dollars per share)     $ 2.46  
Granted, weighted average exercise price (in dollars per share)     $ 7.03  
Exercised, weighted average exercise price (in dollars per share)     $ 1.31  
Unvested options forfeited weighted-average exercise price (in dollars per share)     $ 4.04  
Vested options expired weighted-average exercise price (in dollars per share)     $ 0.81  
Outstanding, weighted average exercise price, end of period (in dollars per share) $ 3.32   $ 3.32  
Vested at end of period weighted average exercise price (in dollars per share) $ 1.87   $ 1.87  
Vested and expected to vest, weighted average exercise price (in dollars per share) $ 3.27 [1]   $ 3.27 [1]  
Stock options, additional disclosures [Abstract]        
Vested at end of period weighted average remaining contractual term     6 years 8 months 12 days  
Vested and expected to vest, weighted average remaining contractual term     7 years 6 months [1]  
Outstanding intrinsic value 64,630,326   64,630,326  
Vested at end of period aggregate intrinsic value 47,252,742   47,252,742  
Vested and expected to vest, aggregate intrinsic value 64,242,362 [1]   64,242,362 [1]  
Exercised options, intrinsic value     6,517,614  
Number of outstanding options (in shares) 16,843,940   16,843,940  
Outstanding Options, weighted average remaining contractual term     7 years 6 months  
Outstanding Options, weighted average exercise price (in dollars per share) $ 3.32   $ 3.32  
Number of exercisable options (in shares) 8,987,368   8,987,368  
Exercisable Options, weighted average exercise price (in dollars per share) $ 1.87   $ 1.87  
Fair value options valuation assumptions [Abstract]        
Expected volatility Minimum     63.60% 61.41%
Expected volatility Maximum     64.50% 64.56%
Expected life (in years)       6 years
Expected dividend yield     0.00% 0.00%
Risk-free interest rate Minimum     1.69% 0.85%
Risk-free interest rate Maximum     1.96% 1.88%
Share-based Compensation [Abstract]        
Share-based compensation expense 3,021,962 1,667,766 8,160,678 4,155,005
Weighted-average grant date fair value for options granted during the period (in dollars per share)     $ 4.09  
Warrants, term     5 years  
Warrants
       
Warrants, Number of Warrants [Roll Forward]        
Warrants outstanding, beginning of period (in shares)     1,284,816  
Warrants exercised (in shares)     (1,079,583)  
Warrants outstanding, end of period (in shares) 205,233   205,233  
Warrants, Weighted-Average Exercise Price per Warrant [Roll Forward]        
Warrants outstanding, beginning of period (in dollars per share)     0.90  
Warrants exercised (in dollars per share)     0.80  
Warrants outstanding, end of period (in dollars per share) 1.42   1.42  
Cost of Products Sold
       
Share-based Compensation [Abstract]        
Share-based compensation expense 70,424 75,287 242,689 198,119
Research and Development
       
Share-based Compensation [Abstract]        
Share-based compensation expense 170,426 110,694 493,078 309,461
Selling, General and Administrative
       
Share-based Compensation [Abstract]        
Share-based compensation expense 2,781,112 1,481,785 7,424,911 3,647,425
$0.50 - $0.76
       
Stock options, additional disclosures [Abstract]        
Exercise Price Range, lower range limit (in dollars per share)     $ 0.50  
Exercise Price Range, upper range limit (in dollars per share)     $ 0.76  
Number of outstanding options (in shares) 720,364   720,364  
Outstanding Options, weighted average remaining contractual term     4 years 8 months 12 days  
Outstanding Options, weighted average exercise price (in dollars per share) $ 0.72   $ 0.72  
Number of exercisable options (in shares) 720,364   720,364  
Exercisable Options, weighted average exercise price (in dollars per share) $ 0.72   $ 0.72  
$0.87 - $1.35
       
Stock options, additional disclosures [Abstract]        
Exercise Price Range, lower range limit (in dollars per share)     $ 0.87  
Exercise Price Range, upper range limit (in dollars per share)     $ 1.35  
Number of outstanding options (in shares) 6,102,250   6,102,250  
Outstanding Options, weighted average remaining contractual term     6 years 10 months 24 days  
Outstanding Options, weighted average exercise price (in dollars per share) $ 1.20   $ 1.20  
Number of exercisable options (in shares) 4,911,058   4,911,058  
Exercisable Options, weighted average exercise price (in dollars per share) $ 1.19   $ 1.19  
$1.40 - $2.29
       
Stock options, additional disclosures [Abstract]        
Exercise Price Range, lower range limit (in dollars per share)     $ 1.40  
Exercise Price Range, upper range limit (in dollars per share)     $ 2.29  
Number of outstanding options (in shares) 1,482,701   1,482,701  
Outstanding Options, weighted average remaining contractual term     5 years 3 months 18 days  
Outstanding Options, weighted average exercise price (in dollars per share) $ 1.64   $ 1.64  
Number of exercisable options (in shares) 1,361,032   1,361,032  
Exercisable Options, weighted average exercise price (in dollars per share) $ 1.65   $ 1.65  
$2.33 - $3.75
       
Stock options, additional disclosures [Abstract]        
Exercise Price Range, lower range limit (in dollars per share)     $ 2.35  
Exercise Price Range, upper range limit (in dollars per share)     $ 3.75  
Number of outstanding options (in shares) 1,842,320   1,842,320  
Outstanding Options, weighted average remaining contractual term     8 years  
Outstanding Options, weighted average exercise price (in dollars per share) $ 2.77   $ 2.77  
Number of exercisable options (in shares) 889,298   889,298  
Exercisable Options, weighted average exercise price (in dollars per share) $ 2.69   $ 2.69  
$3.95 - $5.99
       
Stock options, additional disclosures [Abstract]        
Exercise Price Range, lower range limit (in dollars per share)     $ 3.95  
Exercise Price Range, upper range limit (in dollars per share)     $ 5.99  
Number of outstanding options (in shares) 3,443,402   3,443,402  
Outstanding Options, weighted average remaining contractual term     8 years 7 months 6 days  
Outstanding Options, weighted average exercise price (in dollars per share) $ 5.15   $ 5.15  
Number of exercisable options (in shares) 911,797   911,797  
Exercisable Options, weighted average exercise price (in dollars per share) $ 5.02   $ 5.02  
$6.02 - $8.34
       
Stock options, additional disclosures [Abstract]        
Exercise Price Range, lower range limit (in dollars per share)     $ 6.02  
Exercise Price Range, upper range limit (in dollars per share)     $ 8.34  
Number of outstanding options (in shares) 3,252,903   3,252,903  
Outstanding Options, weighted average remaining contractual term     9 years  
Outstanding Options, weighted average exercise price (in dollars per share) $ 7.03   $ 7.03  
Number of exercisable options (in shares) 193,819   193,819  
Exercisable Options, weighted average exercise price (in dollars per share) $ 6.37   $ 6.37  
Stock Options
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expenses expected to be recognized over a weighted-average period     2 years  
Restricted Stock Awards
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expenses expected to be recognized over a weighted-average period     2 years 1 month 6 days  
Total unrecognized stock-based compensation related to time-based, nonvested restricted stock 4,983,312   4,983,312  
Number of Shares        
Beginning Balance     576,550  
Granted     592,864  
Vested     (154,758)  
Forfeited     (720)  
Ending Balance 1,013,936   1,013,936  
Weighted- Average Grant Date Fair Value        
Beginning Balance (in dollars per share)     $ 5.53  
Granted (in dollars per share)     $ 7.05  
Vested (in dollars per share)     $ 5.72  
Forfeited (in dollars per share)     $ 7.24  
Beginning Balance (in dollars per share) $ 6.40   $ 6.40  
Minimum
       
Fair value options valuation assumptions [Abstract]        
Expected life (in years)     5 years  
Maximum
       
Fair value options valuation assumptions [Abstract]        
Expected life (in years)     6 years  
Consultant
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares of common stock issued     5,611  
Value of common stock issued     $ 39,000  
[1] Includes forfeiture adjusted unvested shares.